After being diagnosed with stage four neuroendocrine cancer in 2022, 51-year-old Veronica Madden is finding stability through new treatment options now available in Scotland. Learning that others have lived with the condition for decades has helped her manage the diagnosis, providing a clearer outlook for patients facing this rare disease.